SBC Medical Group Holdings Incorporated (SBCWW) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

SBC Medical Group Holdings Incorporated (SBCWW) Industrial Operations Profile

SBC Medical Group Holdings Incorporated offers management services to cosmetic treatment centers globally, providing advertising, staff training, clinic design, and medical equipment procurement. With a strong profit margin and a low P/E ratio, the company is positioned within the growing aesthetics and wellness industry.

What Is the Investment Thesis for SBCWW?

SBC Medical Group Holdings Incorporated presents a compelling investment thesis based on its established presence in the growing cosmetic treatment industry and its comprehensive service offerings. With a P/E ratio of 0.5 and a profit margin of 29.4%, the company demonstrates strong profitability relative to its market capitalization of $31.9M. Growth catalysts include the expansion of cosmetic treatment centers in emerging markets and the increasing demand for aesthetic procedures. The company's ability to leverage its established infrastructure and expertise to support franchisee growth is a key value driver. However, potential risks include increased competition in the management services sector and regulatory changes impacting the cosmetic treatment industry. Investors should monitor the company's ability to maintain its profit margins and expand its service offerings to sustain long-term growth.

Based on FMP financials and quantitative analysis

SBCWW Key Highlights

Market capitalization of $31.9M, reflecting its current valuation in the market.

• P/E ratio of 0.5, indicating a potentially undervalued stock relative to its earnings.
• Profit margin of 29.4%, showcasing strong profitability in the consulting services sector.
• Gross margin of 72.9%, highlighting efficient cost management in service delivery.
• Beta of 0.99, suggesting the stock's volatility is similar to the overall market.

Who Are SBCWW's Competitors?

SBCWW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SBCWW's Key Strengths?

Comprehensive suite of management services.

• Established presence in multiple countries.
• Strong relationships with franchisee clinics.
• High profit margin of 29.4%.

What Are SBCWW's Weaknesses?

Small market capitalization of $31.9M.

• Limited brand recognition compared to larger consulting firms.
• Dependence on the cosmetic treatment industry.
• Potential vulnerability to regulatory changes.

What Could Drive SBCWW Stock Higher?

SBCWW catalyst: Expansion into new geographic markets, particularly in Southeast Asia and Latin America, to capitalize on the growing demand for cosmetic procedures.

• Continued development and enhancement of IT software solutions to improve the operational efficiency of franchisee clinics.
• Strategic partnerships with medical equipment suppliers and marketing agencies to offer a more comprehensive solution to clients.
• Investment in training and education programs for franchisee staff to enhance the quality of service.

What Are the Key Risks for SBCWW?

Increased competition from larger consulting firms and specialized management service providers.

• Economic downturn impacting consumer spending on cosmetic procedures.
• Regulatory changes affecting the cosmetic treatment industry, such as stricter licensing requirements or advertising restrictions.
• Negative publicity or reputational damage due to adverse events at franchisee clinics.
• Dependence on the cosmetic treatment industry, which is subject to changing consumer preferences and trends.

What Are the Growth Opportunities for SBCWW?

• Expansion into Emerging Markets: The increasing demand for cosmetic procedures in emerging markets such as Southeast Asia and Latin America presents a significant growth opportunity for SBC Medical Group Holdings. By leveraging its existing expertise and infrastructure, the company can establish new partnerships with cosmetic treatment centers in these regions. This expansion can drive revenue growth and diversify the company's geographic footprint. The global cosmetic surgery and procedures market is projected to reach $43.9 billion by 2028, offering a substantial addressable market for SBC Medical Group Holdings.
• Enhancement of IT Software Solutions: Investing in the development and enhancement of its IT software solutions can provide SBC Medical Group Holdings with a competitive advantage. By offering advanced booking, patient management, and data analytics tools, the company can attract new franchisee clients and improve the operational efficiency of existing clients.
• Development of New Service Offerings: Expanding its service offerings to include complementary services such as marketing consulting, financial planning, and regulatory compliance can enhance the value proposition for franchisee clients. By providing a comprehensive suite of services, SBC Medical Group Holdings can strengthen its relationships with clients and increase its revenue per client. The global management consulting market is projected to reach $883.53 billion by 2028, highlighting the demand for specialized consulting services.
• Strategic Partnerships and Acquisitions: Pursuing strategic partnerships and acquisitions can enable SBC Medical Group Holdings to expand its market reach and enhance its service capabilities. By partnering with complementary businesses such as medical equipment suppliers or marketing agencies, the company can offer a more comprehensive solution to its clients. The mergers and acquisitions market in the healthcare sector remains active, providing opportunities for SBC Medical Group Holdings to grow through strategic acquisitions.
• Focus on Training and Education Programs: Investing in comprehensive training and education programs for franchisee staff can improve the quality of service provided by cosmetic treatment centers and enhance customer satisfaction. By offering specialized training in areas such as customer service, sales, and technical skills, SBC Medical Group Holdings can differentiate itself from competitors and attract new franchisee clients. The global corporate training market is expected to reach $402.6 billion by 2027, indicating a strong demand for professional development and training programs.

What Are SBCWW's Competitive Advantages?

• Established network of cosmetic treatment centers across multiple countries.
• Comprehensive suite of management services tailored to the cosmetic treatment industry.
• Expertise in advertising, marketing, staff management, and clinic design.
• Strong relationships with medical equipment and consumable suppliers.
• Proprietary IT software solutions designed for cosmetic treatment centers.

What Does SBCWW Do?

Founded in 2000 and headquartered in Irvine, California, SBC Medical Group Holdings Incorporated provides comprehensive management services to cosmetic treatment centers across Japan, Vietnam, the United States, and other international markets. The company's services encompass a wide range of operational and strategic support functions, including advertising and marketing, staff recruitment and training, booking reservations, and assistance with franchisee employee housing and facility rentals. SBC Medical Group Holdings also handles the construction and design of franchisee clinics, ensuring a consistent brand experience and operational efficiency. Furthermore, it manages the procurement of medical equipment and consumables, leveraging economies of scale to reduce costs for its franchisees. Beyond operational support, SBC Medical Group Holdings provides IT software solutions tailored to the needs of cosmetic treatment centers. The company supports a diverse array of cosmetic procedures, including breast augmentation, liposuction, rejuvenation treatments, laser skin toning, and various surgical and non-surgical aesthetic enhancements. This holistic approach positions SBC Medical Group Holdings as a key enabler for cosmetic treatment centers seeking to expand their reach and enhance their service offerings.

What Products and Services Does SBCWW Offer?

• Provides advertising and marketing services to cosmetic treatment centers.
• Offers staff management services, including recruitment and training.
• Manages booking reservations for franchisee clinic customers.
• Assists with franchisee employee housing rentals and facility rentals.
• Handles construction and design of franchisee clinics.
• Procures medical equipment and medical consumables.
• Provides IT software solutions tailored to cosmetic treatment centers.
• Supports a diverse array of cosmetic procedures.

How Does SBCWW Make Money?

• Generates revenue by providing management services to cosmetic treatment centers.
• Charges fees for advertising and marketing services.
• Earns revenue from staff management services, including recruitment and training.
• Receives fees for booking reservations and assisting with housing and facility rentals.
• Profits from the construction and design of franchisee clinics and the procurement of medical equipment.

What Industry Does SBCWW Operate In?

SBC Medical Group Holdings operates within the consulting services industry, specifically catering to the cosmetic treatment sector. The global aesthetics market is experiencing steady growth, driven by increasing disposable incomes, an aging population, and a growing emphasis on personal appearance. Key trends include the rising popularity of non-invasive procedures and the expansion of cosmetic services in emerging markets. The competitive landscape includes both specialized management service providers and larger consulting firms that offer broader business solutions. SBC Medical Group Holdings differentiates itself through its focus on the cosmetic treatment industry and its comprehensive suite of services tailored to the specific needs of cosmetic treatment centers.

Who Are SBCWW's Key Customers?

• Cosmetic treatment centers in Japan, Vietnam, and the United States.
• Franchisee clinic customers seeking management and operational support.
• Medical professionals and staff employed by franchisee clinics.
• Patients seeking cosmetic procedures at franchisee clinics.
• Medical equipment and consumable suppliers.

Company Profile

SBC Medical Group Holdings Incorporated operates in the Consulting Services industry within the Industrials sector. It is headquartered in Irvine, US. The company is led by CEO Yoshiyuki Aikawa. SBCWW has traded publicly since 2022.

SBC Medical Group Holdings Incorporated Financial Trajectory

SBC Medical Group Holdings Incorporated (SBCWW) reported $49.2M in revenue for Q2 2026, reflecting 14.2% growth compared to the prior quarter. The company recorded net income of $10.7M, with diluted EPS of $0.10. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Industrials company. Across the four most recent quarters, SBCWW averaged $0.12 in diluted EPS.

How SBC Medical Group Holdings Incorporated Is Valued

SBC Medical Group Holdings Incorporated carries a market capitalization of $31.9M, placing it in the micro-cap category. Relative to its peer group, SBCWW's quantitative score of 60/100 is roughly in line with the peer average of 53/100.

Return on equity for SBC Medical Group Holdings Incorporated stands at 18.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 11.3%, showing how much profit it generates from its asset base. SBCWW trades at a trailing price-to-earnings ratio of 0.53, below the Industrials sector average of ~32x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.31 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

SBC Medical Group Holdings Incorporated's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.60 places it in the grey zone, a middle ground that warrants monitoring.

SBC Medical Group Holdings Incorporated has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 23.0% below estimates on average.

Wall Street analysts project SBC Medical Group Holdings Incorporated revenue of about $181.0M for fiscal 2026, with EPS near $0.46. The estimate reflects 3 contributing analysts.

SBCWW Financials

SBCWW Latest News

No recent news available for SBCWW.

SBCWW Analyst Consensus

SBCWW MoonshotScore

SBCWW Industrials Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources